Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.
Jan 29, 2016
- Jan 26, 2016Journal of Clinical Oncology Publishes Results from the STRIVE trial of enzalutamide Compared to bicalutamide in Castration-resistant Prostate Cancer-Study appears in online edition-
- Jan 22, 2016- ASTELLAS IS COMMITTED TO TRANSACTION, ACQUISITION OF OCATA IS A STRATEGIC PRIORITY -
- Jan 13, 2016Lancet Oncology Publishes Results from the Phase 2 TERRAIN Trial of enzalutamide Compared to bicalutamide in Metastatic Castration-Resistant Prostate Cancer-Study appears in online edition-
- Jan 13, 2016Five-Year Agreement Reflects Shared Commitment to Giving Back In Local Communities and Creating "Must-See" Moments